|
Volumn 31, Issue 6, 2012, Pages 578-582
|
Efficacy and safety of long-term adefovir dipivoxil therapy in children with chronic hepatitis B infection
|
Author keywords
Adolescent; Nucleotide; Resistance; Treatment
|
Indexed keywords
ADEFOVIR DIPIVOXIL;
ALANINE AMINOTRANSFERASE;
BILIRUBIN;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
PLACEBO;
VIRUS DNA;
ADD ON THERAPY;
ADOLESCENT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANTIVIRAL RESISTANCE;
ANTIVIRAL THERAPY;
ARTICLE;
BILIRUBIN BLOOD LEVEL;
CHILD;
CHILDHOOD DISEASE;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG EXPOSURE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
HEPATITIS B;
HUMAN;
LIVER DISEASE;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MONOTHERAPY;
OPEN STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCHOOL CHILD;
SEROCONVERSION;
SIDE EFFECT;
TREATMENT RESPONSE;
ADENINE;
ADOLESCENT;
CHILD;
CHILD, PRESCHOOL;
DNA, VIRAL;
DOUBLE-BLIND METHOD;
DRUG RESISTANCE, VIRAL;
FEMALE;
FOLLOW-UP STUDIES;
HEPATITIS B CORE ANTIGENS;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HUMANS;
MALE;
PHOSPHONIC ACIDS;
PLACEBOS;
TREATMENT OUTCOME;
|
EID: 84861530778
PISSN: 08913668
EISSN: 15320987
Source Type: Journal
DOI: 10.1097/INF.0b013e318255ffe7 Document Type: Article |
Times cited : (20)
|
References (7)
|